Alexander Pohl

EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients

Siwen Hu‐Lieskovan, Daniel Vallböhmer, Wu Zhang et al. · Clinical Cancer Research · 2011 · 49 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy

Alexander Pohl, Anthony B. El-Khoueiry, Dongyun Yang et al. · The Pharmacogenomics Journal · 2012 · 44 citations

Medicine, Oncology, Pharmacology +15

Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer

Alexander Pohl, Mizutomo Azuma, W Zhang et al. · The Pharmacogenomics Journal · 2010 · 40 citations

Medicine, Oncology, Pharmacology +17

Increased resting lactate levels and reduced carbohydrate intake cause νLa.max underestimation by reducing net lactate accumulation—A pilot study in young adults

Alexander Pohl, Frederik Schünemann, Kirill Schaaf et al. · Physiological Reports · 2024 · 11 citations · Full text

Life Sciences, Kinesiology, Physiology +17